Patient Safety Tool: IHI Trigger Tool for Measuring Adverse Drug Events

The Institute for Healthcare Improvement offers free resources to reduce the risk of several types of adverse events, including those related to medication errors.

Advertisement

The IHI Trigger Tool for Measuring Adverse Drug Events provides guidance for retrospective review of patient records to identify potential triggers that may lead to ADEs. The tool includes a list of known triggers as well as instructions for measuring the quantity and quality of ADEs.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Download the tool for use in your own facility.

Note: View our database providing more than 400 reports that link to free downloadable and adaptable tools for use in surgery centers, hospitals and other organizations by clicking here.

More Articles on Infection Control & Clinical Quality:

Best-Practices for Soft Surface Decontamination: Q&A With Dr. Kelly Reynolds

Restrictive Red Blood Cell Transfusion Strategy May Reduce HAI Risk

FMT Colonoscopy Most Cost-Effective Treatment for Recurrent C. diff

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.